Page last updated: 2024-09-02

1,9-dideoxyforskolin and 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol

1,9-dideoxyforskolin has been researched along with 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol in 1 studies

Compound Research Comparison

Studies
(1,9-dideoxyforskolin)
Trials
(1,9-dideoxyforskolin)
Recent Studies (post-2010)
(1,9-dideoxyforskolin)
Studies
(3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol)
Trials
(3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol)
Recent Studies (post-2010) (3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol)
111027110176

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cook, SA; Lichtman, AH; Martin, BR; Welch, SP1

Other Studies

1 other study(ies) available for 1,9-dideoxyforskolin and 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol

ArticleYear
Evaluation of cAMP involvement in cannabinoid-induced antinociception.
    Life sciences, 1995, Volume: 56, Issue:23-24

    Topics: Analgesics; Animals; Colforsin; Cyclic AMP; Cyclohexanols; Dronabinol; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley

1995